What is a stock summary page? Click here for an overview.
Business Description
Titan Biotech Ltd
ISIN : INE150C01011
Share Class Description:
BOM:524717: Shs DematerialisedCompare
Compare
Traded in other countries / regions
524717.India IPO Date
2000-11-30Description
Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The Company's business activity falls within a single primary business segment which is business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.84 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.09 | |||||
| Interest Coverage | 28.54 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 10.5 | |||||
| Beneish M-Score | -2.06 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.9 | |||||
| 3-Year EBITDA Growth Rate | -8.3 | |||||
| 3-Year EPS without NRI Growth Rate | -7.5 | |||||
| 3-Year FCF Growth Rate | -53.2 | |||||
| 3-Year Book Growth Rate | 24.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.39 | |||||
| 9-Day RSI | 56.31 | |||||
| 14-Day RSI | 50.08 | |||||
| 3-1 Month Momentum % | -36.9 | |||||
| 6-1 Month Momentum % | -37.15 | |||||
| 12-1 Month Momentum % | -15.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.97 | |||||
| Quick Ratio | 1.83 | |||||
| Cash Ratio | 0.44 | |||||
| Days Inventory | 177.91 | |||||
| Days Sales Outstanding | 50.23 | |||||
| Days Payable | 20.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.41 | |||||
| Dividend Payout Ratio | 0.07 | |||||
| 3-Year Dividend Growth Rate | 21.6 | |||||
| Forward Dividend Yield % | 0.41 | |||||
| 5-Year Yield-on-Cost % | 0.42 | |||||
| Shareholder Yield % | 1.18 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.67 | |||||
| Operating Margin % | 14.75 | |||||
| Net Margin % | 13.95 | |||||
| FCF Margin % | 0.9 | |||||
| ROE % | 17.1 | |||||
| ROA % | 13.98 | |||||
| ROIC % | 12.13 | |||||
| 3-Year ROIIC % | -15.47 | |||||
| ROC (Joel Greenblatt) % | 23.5 | |||||
| ROCE % | 19.01 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.91 | |||||
| PE Ratio without NRI | 18.26 | |||||
| Shiller PE Ratio | 25.27 | |||||
| Price-to-Owner-Earnings | 21.94 | |||||
| PEG Ratio | 0.65 | |||||
| PS Ratio | 2.5 | |||||
| PB Ratio | 2.78 | |||||
| Price-to-Tangible-Book | 2.78 | |||||
| Price-to-Free-Cash-Flow | 276.32 | |||||
| Price-to-Operating-Cash-Flow | 19.04 | |||||
| EV-to-EBIT | 14.89 | |||||
| EV-to-EBITDA | 12.87 | |||||
| EV-to-Revenue | 2.45 | |||||
| EV-to-FCF | 271.26 | |||||
| Price-to-GF-Value | 1.18 | |||||
| Price-to-Projected-FCF | 7.67 | |||||
| Price-to-DCF (Earnings Based) | 0.7 | |||||
| Price-to-DCF (FCF Based) | 10.62 | |||||
| Price-to-Median-PS-Value | 2.76 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.3 | |||||
| Price-to-Graham-Number | 1.41 | |||||
| Price-to-Net-Current-Asset-Value | 6.36 | |||||
| Earnings Yield (Greenblatt) % | 6.72 | |||||
| FCF Yield % | 0.36 | |||||
| Forward Rate of Return (Yacktman) % | 6.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Titan Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,612.002 | ||
| EPS (TTM) (₹) | 27.194 | ||
| Beta | 0.58 | ||
| 3-Year Sharpe Ratio | 0.43 | ||
| 3-Year Sortino Ratio | 0.68 | ||
| Volatility % | 61.66 | ||
| 14-Day RSI | 50.08 | ||
| 14-Day ATR (₹) | 31.160429 | ||
| 20-Day SMA (₹) | 453.28 | ||
| 12-1 Month Momentum % | -15.28 | ||
| 52-Week Range (₹) | 406.7 - 1017.85 | ||
| Shares Outstanding (Mil) | 8.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Titan Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Titan Biotech Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Titan Biotech Ltd Frequently Asked Questions
What is Titan Biotech Ltd(BOM:524717)'s stock price today?
The current price of BOM:524717 is ₹487.15. The 52 week high of BOM:524717 is ₹1017.85 and 52 week low is ₹406.70.
When is next earnings date of Titan Biotech Ltd(BOM:524717)?
The next earnings date of Titan Biotech Ltd(BOM:524717) is .
Does Titan Biotech Ltd(BOM:524717) pay dividends? If so, how much?
The Dividend Yield %  of Titan Biotech Ltd(BOM:524717) is 0.41% (As of Today), Highest Dividend Payout Ratio of Titan Biotech Ltd(BOM:524717) was 0.36. The lowest was 0.03. And the median was 0.17. The  Forward Dividend Yield % of Titan Biotech Ltd(BOM:524717) is 0.41%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers